Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

Abstract Introduction Controlled clinical studies have shown that the efficacy of tocilizumab (TCZ) monotherapy is superior to that of tumor necrosis factor inhibitor (TNFi) monotherapy and comparable to that of TCZ plus methotrexate (MTX) for the treatment of rheumatoid arthritis (RA). This study c...

Full description

Bibliographic Details
Main Authors: Leslie R. Harrold, George W. Reed, Jennie Best, Steve Zlotnick, Joel M. Kremer
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-10-01
Series:Rheumatology and Therapy
Subjects:
Biological therapy
Comparative effectiveness research
Interleukin-6
Methotrexate
Monotherapy
Registries
Online Access:http://link.springer.com/article/10.1007/s40744-018-0127-1

Internet

http://link.springer.com/article/10.1007/s40744-018-0127-1

Similar Items